Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T85467 | Target Info | |||
| Target Name | Prostaglandin E2 receptor EP3 (PTGER3) | ||||
| Synonyms | Prostanoid EP3 receptor; Prostaglandin E2 receptor EP3 subtype; PGE2-R; PGE2 receptor EP3 subtype; PGE receptor, EP3 subtype; PGE receptor EP3 subtype | ||||
| Target Type | Clinical trial Target | ||||
| Gene Name | PTGER3 | ||||
| Biochemical Class | GPCR rhodopsin | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| United States Patent and Trademark Office (USPTO) | |||||
| Patent ID | US02014179750 | ||||
| Title | Prostaglandin Receptor Ep2 Antagonists, Derivatives, Compositions, and Uses Related Thereto. | ||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Evaluation of WO 2012/177618 A1 and US-2014/0179750 A1: novel small molecule antagonists of prostaglandin-E2 receptor EP2.Expert Opin Ther Pat. 2015 Jul;25(7):837-44. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.